Barcelon, Marivic B.

HRN: 23-39-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
CEFUROXIME 1.5GM (VIAL)
08/15/2023
08/22/2023
IV
1.5g
Q8
For CS
Checking Final Appropriateness 
08/17/2023
CEFUROXIME 500MG (TAB)
08/17/2023
08/24/2023
PO
500mg Tab
BID
Post OP Prophylaxis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: